Singapore Paincare brings Western treatment and TCM together in new Chinese JV
Megan Cheah
DeeperDive is a beta AI feature. Refer to full articles for the facts.
MEDICAL services group Singapore Paincare Holdings (SPCH) is partnering Chinese community hospital operator Puxiang Healthcare to bring its specialist pain-care treatments to China and widen its pool of patients.
The Catalist-listed group has signed a non-exhaustive, non-binding term sheet with Beijing Puxiang Hospital Investment Management Co (BPHIM), a wholly-owned subsidiary of Puxiang Healthcare, to set up a joint venture (JV) company, PuXin Pain Technology Hospital Management Company.
SPCH will own 49 per cent of the JV, with BPHIM holding the remaining 51 per cent.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.